197 related articles for article (PubMed ID: 20553613)
81. [Topoisomerase IIalpha and HER2/neu gene alterations and their correlation in pancreatic ductal adenocarcinomas].
Liang ZY; Wang WZ; Gao J; Wu SF; Zeng X; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):102-6. PubMed ID: 17493384
[TBL] [Abstract][Full Text] [Related]
82. MutY-Homolog (MYH) inhibition reduces pancreatic cancer cell growth and increases chemosensitivity.
Sharbeen G; Youkhana J; Mawson A; McCarroll J; Nunez A; Biankin A; Johns A; Goldstein D; Phillips P
Oncotarget; 2017 Feb; 8(6):9216-9229. PubMed ID: 27999205
[TBL] [Abstract][Full Text] [Related]
83. Pachymic acid inhibits growth and induces apoptosis of pancreatic cancer in vitro and in vivo by targeting ER stress.
Cheng S; Swanson K; Eliaz I; McClintick JN; Sandusky GE; Sliva D
PLoS One; 2015; 10(4):e0122270. PubMed ID: 25915041
[TBL] [Abstract][Full Text] [Related]
84. Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors.
Balko JM; Potti A; Saunders C; Stromberg A; Haura EB; Black EP
BMC Genomics; 2006 Nov; 7():289. PubMed ID: 17096850
[TBL] [Abstract][Full Text] [Related]
85. Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth.
Vincent A; Hong SM; Hu C; Omura N; Young A; Kim H; Yu J; Knight S; Ayars M; Griffith M; Van Seuningen I; Maitra A; Goggins M
Oncotarget; 2014 May; 5(9):2575-87. PubMed ID: 24810906
[TBL] [Abstract][Full Text] [Related]
86. SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2.
Masuo K; Chen R; Yogo A; Sugiyama A; Fukuda A; Masui T; Uemoto S; Seno H; Takaishi S
Cancer Sci; 2021 Dec; 112(12):4987-4999. PubMed ID: 34628696
[TBL] [Abstract][Full Text] [Related]
87. Apoptotic activity and antitumor efficacy of PEGylated TNF-related apoptosis-inducing ligand (TRAIL) in a Mia Paca-2 cell-xenografted mouse model.
Byeon HJ; Choi SH; Choi JS; Kim TH; Lee ES; Lee KC; Youn YS
Biomed Pharmacother; 2014 Feb; 68(1):65-9. PubMed ID: 24268811
[TBL] [Abstract][Full Text] [Related]
88. Impact of Hybrid-polar Histone Deacetylase Inhibitor m-Carboxycinnamic Acid bis-Hydroxyamide on Human Pancreatic Adenocarcinoma Cells.
Kumar D; Sarma P; Bhadra MP; Tangutur AD
Anticancer Agents Med Chem; 2019; 19(6):750-759. PubMed ID: 30621566
[TBL] [Abstract][Full Text] [Related]
89. Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer.
Sette G; Salvati V; Mottolese M; Visca P; Gallo E; Fecchi K; Pilozzi E; Duranti E; Policicchio E; Tartaglia M; Milella M; De Maria R; Eramo A
Cell Death Dis; 2015 Aug; 6(8):e1850. PubMed ID: 26247735
[TBL] [Abstract][Full Text] [Related]
90. Overexpression of human Argonaute2 inhibits cell and tumor growth.
Zhang X; Graves P; Zeng Y
Biochim Biophys Acta; 2013 Mar; 1830(3):2553-61. PubMed ID: 23201202
[TBL] [Abstract][Full Text] [Related]
91. Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease.
Mackinnon AC; Tretiakova M; Henderson L; Mehta RG; Yan BC; Joseph L; Krausz T; Husain AN; Reid ME; Salgia R
J Clin Pathol; 2011 Jan; 64(1):16-24. PubMed ID: 21045234
[TBL] [Abstract][Full Text] [Related]
92. TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes.
Eyres M; Lanfredini S; Xu H; Burns A; Blake A; Willenbrock F; Goldin R; Hughes D; Hughes S; Thapa A; Vavoulis D; Hubert A; D'Costa Z; Sabbagh A; Abraham AG; Blancher C; Jones S; Verrill C; Silva M; Soonawalla Z; Maughan T; Schuh A; Mukherjee S; O'Neill E
Gastroenterology; 2021 Aug; 161(2):653-668.e16. PubMed ID: 33915173
[TBL] [Abstract][Full Text] [Related]
93. MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2.
Sun Y; Zhang T; Wang C; Jin X; Jia C; Yu S; Chen J
PLoS One; 2015; 10(4):e0119783. PubMed ID: 25856297
[TBL] [Abstract][Full Text] [Related]
94. Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cells.
Kan S; Koido S; Okamoto M; Hayashi K; Ito M; Kamata Y; Komita H; Nagasaki E; Homma S
BMC Cancer; 2015 Oct; 15():726. PubMed ID: 26475267
[TBL] [Abstract][Full Text] [Related]
95. KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model.
McNally LR; Welch DR; Beck BH; Stafford LJ; Long JW; Sellers JC; Huang ZQ; Grizzle WE; Stockard CR; Nash KT; Buchsbaum DJ
Clin Exp Metastasis; 2010 Dec; 27(8):591-600. PubMed ID: 20844932
[TBL] [Abstract][Full Text] [Related]
96. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
[TBL] [Abstract][Full Text] [Related]
97. Perforin-dependent direct cytotoxicity in natural killer cells induces considerable knockdown of spontaneous lung metastases and computer modelling-proven tumor cell dormancy in a HT29 human colon cancer xenograft mouse model.
Brodbeck T; Nehmann N; Bethge A; Wedemann G; Schumacher U
Mol Cancer; 2014 Nov; 13():244. PubMed ID: 25373310
[TBL] [Abstract][Full Text] [Related]
98. Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists.
Morimoto M; Matsuo Y; Koide S; Tsuboi K; Shamoto T; Sato T; Saito K; Takahashi H; Takeyama H
BMC Cancer; 2016 May; 16():305. PubMed ID: 27175473
[TBL] [Abstract][Full Text] [Related]
99. ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma.
Liles JS; Arnoletti JP; Tzeng CW; Howard JH; Kossenkov AV; Kulesza P; Heslin MJ; Frolov A
Cancer Biol Ther; 2010 Sep; 10(6):555-63. PubMed ID: 20647770
[TBL] [Abstract][Full Text] [Related]
100. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]